Introducing NeuroAI
NeuroAI: Redefining Brain Health Diagnostics
Advanced Diagnostics
FDA-cleared eye-tracking technology delivers precise neurological assessments instantly.
AI-Powered Analysis
Continuous learning algorithms refine diagnostic accuracy for personalized care.
Accessible Expertise
Empowers all clinicians to deliver specialist-level neurological care.
Global Impact
Contributes to research while improving patient outcomes worldwide.
Core Technology: An Integrated Ecosystem
NeuroAI Cloud Platform
DX200 Virtual 3D VNG Goggles
NOTC Pro+ Rotary Chair
Falcon vHIT Goggles
CX100 At-Home Devices
NeuroAI Precision Analytics
Advanced AI-driven algorithms that continuously refine diagnostics, predict patient outcomes, and personalize neurological care in real time
Comprehensive Solution Suite
DX200 VNG Goggles
Revolutionary eye-tracking technology that detects micro-movements. Captures precise data for immediate diagnosis of neurological impairments.
NOTC Pro+ Rotary Chair
Gold-standard vestibular assessment with six degrees of motion. Delivers comprehensive balance evaluation with automatic software updates.
Falcon vHIT Goggles
Ultra-sensitive motion sensors track vestibulo-ocular reflexes. Identifies subtle balance disorders within minutes.
CX100 At-Home Monitoring
Remote neurological assessment between clinical visits. Enables continuous care and early intervention for progressive conditions.
NeuroAI at a Glance
Our pioneering neurological diagnostic platform combines decades of clinical experience with cutting-edge AI technology.
800
Test Variables
26
Clinical Tests
200+
Customer Sites
Trusted by leading neurological clinics worldwide
30+
Patents
Proprietary technology with robust IP protection
Backed by 60+ peer-reviewed publications and 30+ years of combined clinical expertise, NeuroAI delivers unmatched diagnostic precision.
NeuroAI Protocols
Precisely Designed Assessment Montages
Neuro-Check: Comprehensive neurological screening to assess overall brain health.
NeuroCheck delivers comprehensive, AI-powered neurological screening to detect issues early, guide personalized care, and set a new standard in brain health management.
What is NeuroCheck?
NeuroCheck is a comprehensive neurological screening protocol that provides a full-spectrum assessment of brain health. Built on NeuroAI’s advanced technology, NeuroCheck integrates eye tracking, vestibular evaluations, and cognitive assessments into one streamlined, non-invasive solution. It is designed to detect subtle abnormalities and early warning signs of neurological conditions that traditional diagnostic methods often miss.
How NeuroCheck Works
Patients undergo a series of non-invasive tests assessing cognitive performance, balance, visual tracking, and neurological stability. The collected data is analyzed by NeuroAI’s powerful algorithms, uncovering patterns that indicate potential neurological risk. Clinicians receive a detailed, actionable report that supports earlier and more accurate diagnosis, targeted interventions, and individualized treatment planning.
Clinical Impact of NeuroCheck
NeuroCheck empowers clinicians to intervene early, improving patient outcomes and reducing the long-term burden of neurological disease. Its data-driven approach enables personalized care pathways based on each patient’s unique neurological profile. By setting a new benchmark for proactive brain health monitoring, NeuroCheck enhances patient engagement, supports preventive care models, and strengthens clinical practices seeking to lead in neurological excellence.
Fall Prevention: Fall Prevention Targeted assessments to identify and mitigate fall risks in patients.
Fall Prevention provides targeted, data-driven neurological assessments to identify fall risk early and deliver personalized interventions that improve stability and reduce injuries.
What is Fall Prevention?
Fall Prevention is a specialized neurological protocol designed to assess key risk factors contributing to falls, including balance, gait, and vestibular function. Falls are a major health concern, particularly for older adults and individuals with neurological conditions, leading to serious injury, loss of independence, and increased healthcare costs. Fall Prevention uses NeuroAI’s advanced assessment technologies to identify subtle functional impairments before they result in a catastrophic event.
How Fall Prevention Works
The protocol combines a series of non-invasive tests, including eye tracking, vestibular evaluations, and motion-based balance analysis. Data from these assessments are processed through NeuroAI’s proprietary algorithms, which analyze coordination, movement, and postural control to detect hidden vulnerabilities. Clinicians receive a comprehensive risk profile and clinical recommendations to guide early, targeted interventions.
Clinical Impact of Fall Prevention
By addressing fall risk proactively, Fall Prevention helps reduce injuries, hospitalizations, and long-term disability associated with falls. It enables clinicians to implement individualized treatment plans, such as physical therapy, balance training, or home safety modifications, based on objective neurological data. The protocol not only improves patient safety and outcomes but also strengthens preventive care models within clinical practice.
TBI-Check: Specialized protocol for assessing and managing traumatic brain injuries.
TBI Check delivers advanced, AI-driven assessment of traumatic brain injuries, providing early detection, precise diagnosis, and personalized recovery pathways to optimize patient outcomes.
What is TBI Check?
TBI Check is a specialized protocol designed to assess, diagnose, and manage traumatic brain injuries using advanced NeuroAI technology. Traumatic brain injuries are a significant healthcare challenge, often resulting from falls, motor vehicle accidents, sports injuries, or physical assaults. TBI Check provides a comprehensive, objective evaluation of cognitive, vestibular, and oculomotor functions to support early diagnosis and effective clinical management.
How TBI Check Works
Patients undergo a series of non-invasive assessments measuring key neurological functions affected by head trauma, including balance, cognitive performance, and eye movement control. The data is processed using NeuroAI’s proprietary algorithms, which detect subtle changes in brain function that may not be visible through traditional assessments. Clinicians receive detailed, actionable reports that identify injury severity, affected systems, and guide targeted rehabilitation strategies.
Clinical Impact of TBI Check
TBI Check significantly improves the early detection and management of traumatic brain injuries, helping clinicians prevent long-term complications such as cognitive decline, vestibular dysfunction, and post-concussion syndrome. Its AI-enhanced analysis ensures that no subtle deficit is overlooked, enabling timely, precise interventions. By supporting comprehensive, individualized care, TBI Check elevates the clinical standard for TBI management and long-term patient recovery.
NeuroElite: NeuroElite Neurological performance assessment for athletes and high-performing individuals.
NeuroElite delivers precision neurological assessments and performance optimization plans for athletes, military personnel, and high-performing individuals seeking to enhance cognitive and motor excellence.
What is NeuroElite?
NeuroElite is a specialized NeuroAI protocol designed to assess and optimize neurological performance in athletes, military personnel, and other high-performing professionals. Traditional clinical assessments often fail to meet the rigorous demands of elite performers; NeuroElite bridges this gap by offering comprehensive, objective evaluations of cognitive speed, motor coordination, visual tracking, and decision-making ability. The protocol aims to maximize performance potential while supporting overall brain health and resilience.
How NeuroElite Works
The protocol involves a series of targeted assessments that measure cognitive processing, balance, visual tracking, and motor function with high precision. Utilizing NeuroAI’s advanced high-speed eye tracking and AI-powered analytics, NeuroElite identifies both areas of strength and performance vulnerabilities. Following analysis, a personalized performance enhancement plan is developed, combining cognitive exercises, motor training, and strategic lifestyle recommendations to optimize neurological efficiency.
Clinical Impact of NeuroElite
NeuroElite enables high-performing individuals to elevate their performance while proactively addressing subtle neurological imbalances that could impair future achievement. By delivering objective insights and individualized optimization strategies, the protocol supports peak performance sustainability, injury prevention, and cognitive resilience. NeuroElite provides a new standard of neurological care for those operating at the highest levels of mental and physical demand.
PD-Check: Focused assessments for the early identification and management of Parkinson’s disease.
The Parkinson’s Protocol delivers advanced, AI-powered assessments to support early detection, personalized management, and long-term monitoring of Parkinson’s disease progression.
What is the PD-Check?
The Parkinson’s Protocol is a specialized NeuroAI system designed to support the early identification, monitoring, and management of Parkinson’s disease. Using a combination of detailed neurological assessments and AI-enhanced data analysis, the protocol detects subtle motor and cognitive changes that traditional examinations may miss. Early detection enables more effective intervention strategies, improving clinical outcomes and preserving patient quality of life.
How the Parkinson’s Protocol Works
Patients complete a series of targeted assessments evaluating gait, balance, fine motor skills, and neurological stability. These evaluations are enhanced by high-speed motion tracking and advanced AI algorithms that analyze subtle patterns of dysfunction associated with early Parkinson’s disease. The results provide clinicians with precise insights, supporting accurate diagnosis, individualized care planning, and ongoing adjustment of treatment strategies.
Clinical Impact of PD-Check
The Parkinson’s Protocol addresses a critical gap in neurological care by shifting detection to the earliest possible stages, often before significant motor symptoms emerge. By providing objective, actionable data, the protocol allows for proactive intervention, slowing disease progression, enhancing functional outcomes, and maintaining independence for patients living with Parkinson’s disease.
Dementia & Mild Cognitive Impairment Protocol: Early detection and continuous monitoring of cognitive decline and dementia-related disorders.
The Dementia Protocol provides advanced, AI-powered early detection and continuous monitoring of cognitive decline, enabling timely intervention and personalized care for individuals at risk of dementia.
What is the Dementia Protocol?
The Dementia Protocol is a specialized NeuroAI system designed to support the early detection, diagnosis, and management of dementia and related cognitive disorders. By identifying subtle cognitive impairments before they manifest into significant functional decline, the protocol enables earlier intervention strategies that can slow disease progression and enhance patient quality of life. The use of advanced neurological assessments combined with AI-enhanced data analysis offers a new standard in cognitive health management.
How the Dementia Protocol Works
Patients complete a comprehensive series of non-invasive tests measuring key cognitive domains including memory, attention, executive function, and language. Eye tracking and neurological assessments are integrated to capture a full picture of brain function. NeuroAI’s proprietary algorithms analyze the collected data, detecting patterns of early cognitive decline that may not be visible through conventional evaluations. Clinicians receive detailed reports to inform diagnosis, therapeutic planning, and ongoing monitoring strategies.
Clinical Impact of the Dementia Protocol
The Dementia Protocol enables clinicians to initiate treatment during the critical early stages of cognitive decline, significantly improving patient outcomes and prolonging independence. Its objective, AI-driven analysis enhances diagnostic accuracy, supports dynamic treatment planning, and facilitates close tracking of disease progression. By offering patients and families earlier clarity and structured ongoing support, the protocol represents a major advancement in the management of cognitive disorders.
Equilibrium: Advanced diagnostics for balance and vestibular function disorders.
Equilibrium provides advanced, AI-driven diagnostics for balance and vestibular function disorders, enabling precise identification, targeted treatment, and improved patient stability.
What is Equilibrium?
Equilibrium is a specialized NeuroAI protocol focused on the comprehensive assessment and management of balance and vestibular function disorders. Balance impairments can have profound effects on patient safety and independence, often leading to dizziness, falls, and significant declines in quality of life. By combining vestibular, ocular, and postural evaluations with AI-enhanced data analysis, Equilibrium enables clinicians to identify underlying causes of instability with greater precision than traditional methods.
How Equilibrium Works
The protocol involves a series of non-invasive assessments targeting vestibular function, eye movement control, and postural stability. Tests may include vestibular head impulse testing, computerized dynamic posturography, and advanced eye tracking evaluations. NeuroAI’s proprietary algorithms analyze the collected data to detect abnormalities and subtle dysfunction patterns. Clinicians receive a comprehensive diagnostic report that supports accurate diagnosis and guides the development of individualized rehabilitation strategies.
Clinical Impact of Equilibrium
Equilibrium advances the clinical management of balance disorders by delivering objective, detailed diagnostic insights that lead to more effective interventions. Early and accurate identification of vestibular and balance dysfunction reduces the risk of falls, enhances patient mobility, and supports higher quality of life. The protocol is particularly valuable in complex or chronic cases where traditional diagnostic methods may be insufficient.
Cognicheck - In Development - Proactive Cognitive Wellness for Aging Populations
Cogni-Check delivers proactive cognitive wellness screening for aging populations, enabling early identification of cognitive decline risks and supporting preventative brain health strategies.
What is Cogni-Check?
Cogni-Check is a specialized NeuroAI protocol designed to support cognitive wellness in aging populations through early detection of subtle cognitive changes. As cognitive decline often begins long before functional impairments become obvious, Cogni-Check provides an evidence-based method to identify risks early, implement preventative strategies, and sustain cognitive function over time. This protocol promotes healthy brain aging by offering structured, objective cognitive monitoring.
How Cogni-Check Works
Patients complete a comprehensive series of non-invasive cognitive and neuro-ocular assessments targeting memory, executive function, attention, and processing speed. NeuroAI’s proprietary AI algorithms analyze the collected data to detect early cognitive changes that may signal risk for conditions such as Mild Cognitive Impairment (MCI) or dementia. The system generates detailed reports for clinicians, supporting targeted lifestyle recommendations, cognitive training plans, and, when appropriate, referrals for further neurological evaluation.
Clinical Impact of Cogni-Check
Cogni-Check enables clinicians to shift from reactive treatment to proactive brain health management, helping patients preserve independence and quality of life. By identifying early cognitive vulnerabilities and supporting brain health interventions, Cogni-Check empowers aging individuals to actively engage in maintaining cognitive resilience. This preventative approach also helps healthcare systems reduce the burden of late-stage cognitive disease management.
Revolutionary Neurological Diagnostics
Experts in Neurological Diagnostics
Most Advanced Technology
AI Driven Goggles provide real-time eye-tracking analysis to detect neurological impairments instantly.
Expert Analysis & Timely Results
Our AI-Powered Clinical Decision Support System guides clinicians with actionable insights.
Comprehensive Testing Suite
We offer over 40 brain function tests, from oculomotor to vestibular to cognitive.
Continuous Monitoring
Remote at-home devices track recovery progress, ensuring consistent patient care beyond the clinic.
DX Series Software
Spryson’s software offers an intuitive, visually streamlined interface within a unified, powerful platform.
Key Features
- Powerful Clinical Utility: Create customized protocols and perform advanced, clinical and research-grade assessments.
- Optimized Efficiency: Conduct rapid patient evaluations with precise, reliable analytical results.
- Real-Time Feedback: Experience high-quality data visualization and immediate feedback.
- Clear Reporting: Generate easy-to-understand patient reports featuring clearly defined normative data for every test.
- Enhanced Security: Advanced data protection measures ensuring confidentiality, integrity, and secure user access.
FDA Clearance
Spryson’s DX Series Software (VEST™) is currently FDA-cleared to provide diagnostic support for comprehensive brain health assessments, delivering reliable and clinically validated evaluations. The Spryson Platform allows clinicians and researchers the ability to compare individual results over time and to benchmark against FDA-cleared normative data.
